Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares fell 5% during trading on Monday . The company traded as low as GBX 1.49 and last traded at GBX 1.52. Approximately 552,378 shares traded hands during mid-day trading, a decline of 71% from the average session volume of 1,893,829 shares. The stock had previously closed at GBX 1.60.
Cizzle Biotechnology Stock Down 5.0%
The stock has a 50-day simple moving average of GBX 1.79 and a two-hundred day simple moving average of GBX 2.22. The firm has a market cap of £6.46 million, a PE ratio of -8.94 and a beta of 0.02.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
See Also
- Five stocks we like better than Cizzle Biotechnology
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
